Clinical research progress of Traditional Chinese Medicine treating precancerous lesions of gastric cancer with syndrome differentiation
10.3760/cma.j.cn115398-20201229-00315
- VernacularTitle:中医辨证论治胃癌前病变临床研究进展
- Author:
Yang ZHANG
1
;
Jing REN
;
Yue ZHAO
;
Weidong WU
;
Yueyue DING
;
Ting CHENG
;
Meijiao SUI
Author Information
1. 黑龙江中医药大学附属第一医院肝脾胃病科，哈尔滨 150040
- Keywords:
Precancerous conditions;
Precancerous lesions of gastric cancer;
Traditional Chinese Medicine therapy;
Treatment based on syndrome differentiation;
Resear
- From:
International Journal of Traditional Chinese Medicine
2022;44(2):229-232
- CountryChina
- Language:Chinese
-
Abstract:
Traditional Chinese Medicine (TCM) has certain advantages in the treatment of precancerous lesions of gastric cancer (PLGC) based on the holistic concept and the thought of syndrome differentiation. Currently, it is generally divided into 6 kinds of syndromes: liver and stomach qi stagnation syndrome, liver and stomach heat stagnation syndrome, spleen and stomach weakness syndrome (including spleen and stomach qi deficiency syndrome with coldness), spleen and stomach damp heat syndrome, stomach yin deficiency syndrome and blood stasis in stomach collateral syndrome. Clinically, the doctor should treat PLGC patients according to different syndrome types by using Chinese medicine prescription, which could improve the gastric mucosal pathological state, gastroscopy and clinical symptoms, to rehibit the development of precancerous lesions, reduce the incidence rate of gastric cancer. In the future, the doctors shouldreach the consensus of treating PLGC with TCM diagnosis, and focus on the research of TCM compounds or monomers with obvious curative effect, increase the times of follow-up, and evaluate the long-term curative effect.
